CNS PHARMACEUTICALS INC (CNSP)
US18978H3003 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.97M | 548.72K | 10.06M | 5.00M | 14.04M | |||
| Other Current Assets | 414.97K | 1.04M | 2.51M | 2.47M | 1.46M | |||
| Total Current Assets | 7.39M | 1.59M | 12.56M | 7.48M | 15.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.80K | 4.93K | 10.00K | 20.00K | 20.00K | |||
| Other Non-Current Assets | 18.37K | 104.75K | 480.00K | 1.26M | 330.00K | |||
| Total Non-Current Assets | 21.17K | 109.68K | 490.00K | 1.28M | 350.00K | |||
| TOTAL ASSETS | 7.41M | 1.70M | 13.05M | 8.76M | 15.85M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 31.19K | 300.81K | 410.00K | 390.00K | 440.00K | |||
| Accrued Expenses | N/A | N/A | 830.00K | 220.00K | 520.00K | |||
| Accounts Payable | 4.03M | 5.83M | 3.68M | 1.98M | 950.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 4.06M | 6.13M | 4.92M | 2.59M | 1.91M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 4.06M | 6.13M | 4.92M | 2.59M | 1.91M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -81.25M | -69.57M | -50.72M | -35.44M | -20.95M | |||
| Additional Paid In Capital | 84.57M | 65.13M | 58.85M | 41.60M | 34.87M | |||
| Common Shares | 33.45K | 6.21K | 0.00 | 0.00 | 20.00K | |||
| Shares Outstanding | 33.45M | 124.29K | 1.62M | 950.00K | 800.00K | |||
| Tangible Book Value per Share | 0.10 | -35.66 | 5.02 | 6.48 | 17.44 | |||
| Total Shareholders' Equity | 3.35M | -4.43M | 8.13M | 6.16M | 13.95M | |||
| TOTAL LIABILITIES AND EQUITY | 7.41M | 1.70M | 13.05M | 8.76M | 15.85M | |||
| Statistics | ||||||||
| Current Ratio | 1.82 | 0.26 | 2.55 | 2.89 | 8.12 | |||
| Return On Assets (ROA) | -230.21% | -1108.34% | -117.01% | -165.53% | -59.68% | |||
| Return On Equity (ROE) | -508.80% | N/A | -187.82% | -235.39% | -67.81% | |||
All data in USD , ROIC based on taxRate of 0.21